| # | Drug | Count |
|---|---|---|
| 0 | IBRUTINIB | 31 |
| 1 | RITUXIMAB | 29 |
| 2 | VENETOCLAX | 29 |
| 3 | PREDNISONE | 14 |
| 4 | CYCLOPHOSPHAMIDE | 13 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 13 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 13 |
| 7 | FOLIC ACID | 12 |
| 8 | METHOTREXATE SODIUM | 12 |
| 9 | ALLOPURINOL | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CODEINE PHOSPHATE AND GUAIFENESIN | 1 | 0.0093 |
| 1 | AVOBENZONE, HOMOSALATE, OCTISALAT, OCTOCRYLENE | 1 | 0.0071 |
| 2 | AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE | 1 | 0.0067 |
| 3 | IMIPRAMINE HYDROCHLORIDE | 2 | 0.0035 |
| 4 | BORON | 1 | 0.0033 |
| 5 | PIRTOBRUTINIB | 3 | 0.0031 |
| 6 | CHLORAMBUCIL | 9 | 0.0023 |
| 7 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | 1 | 0.0022 |
| 8 | TAFASITAMAB-CXIX | 1 | 0.0011 |
| 9 | PRASTERONE | 3 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 48 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 36 |
| 2 | BCL-2 Inhibitor [EPC] | 29 |
| 3 | Corticosteroid [EPC] | 23 |
| 4 | Alkylating Drug [EPC] | 19 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 7 | Platinum-based Drug [EPC] | 14 |
| 8 | Vitamin C [EPC] | 14 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 29 | 0.0005 |
| 1 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 3 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 3 | 0.0002 |
| 4 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 3 | 0.0002 |
| 6 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 8 | Standardized Insect Venom Allergenic Extract [EPC] | 1 | 0.0001 |
| 9 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |